Señales en vivo de 300601.SZ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 abr 2024 @ 21:52):

Shenzhen Kangtai Biological Products Co., Ltd. researches, develops, produces, and sells various types of human vaccines in China. The company's products include cell-free whitebait b-type haemophilus influenzae combined vaccine, SARS-COV-2 vaccine, recombinant hepatitis B vaccine, 23-valent pneumococcal polysaccharide vaccine, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccine, haemophilus influenzae type b conjugate vaccine, measles and rubella combined with live attenuated vaccine, 13-valent pneumococcal conjugate vaccine, rabies vaccine, inactivated poliomyelitis vaccine, and HIB conjugate vaccine...

Stats
Volumen de hoy	10.13M
Volumen promedio	11.04M
Capitalización de mercado	21.73B
EPS	CNY0.170 ( 2023-10-26 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	76.08
ATR14	CNY0.120 (0.61%)

Volumen Correlación

Largo: -0.29 (neutral)

Corto: -0.65 (weak negative)

Signal:(35.101) Neutral

Shenzhen Kangtai Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Shenzhen Kangtai Correlación - Moneda/Commodity

0.46
( neutral )

0.41
( neutral )

0.00
( neutral )

0.61
( weak )

0.21
( neutral )

-0.42
( neutral )

Shenzhen Kangtai Finanzas

Annual	2022
Ingresos:	CNY3.16B
Beneficio Bruto:	CNY2.66B (84.17 %)
EPS:	CNY-0.120

FY	2022
Ingresos:	CNY3.16B
Beneficio Bruto:	CNY2.66B (84.17 %)
EPS:	CNY-0.120

FY	2021
Ingresos:	CNY3.65B
Beneficio Bruto:	CNY2.67B (72.99 %)
EPS:	CNY1.850

FY	2020
Ingresos:	CNY2.26B
Beneficio Bruto:	CNY2.03B (89.99 %)
EPS:	CNY1.030

Financial Reports:

No articles found.

Shenzhen Kangtai